Manufacturer record
Torque Pharmaceuticals Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Torque Pharmaceuticals Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between January 2019 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
5 records linked to Torque Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Levocetirizine Dihydrochloride Tablets I.P. | B13225006Mfg 2025-11 · Exp 2027-10 | The sample does not conform to the I.P. with respect to Dissolution of Levocetirizine Dihydrochloride.Dissolution | DTL JodhpurState lab | Jul 2026 |
| MONTOR -LC TABLET (MONTELUKAST SODIUM & LEVOCETRIZINE DIHYDROCHLORI DE TABLET I.P.) | B18523001Mfg 2023-01 · Exp 2024-12 | THE SAMPLE DOES NOT COMPLY WITH I P REQUIREMENTS FOR DISSOLUTION TESTDissolution | State Lab MaharashtraState lab | Jun 2024 |
| Montelukast Sodium & Levocetirizine Dihydrochloride Tables I.P. (Montor - LC Tablets) | B18523003Mfg 2023-03 · Exp 2025-02 | DissolutionDissolution | CDL KolkataCDSCO lab | Mar 2024 |
| Ornigyl-O (Ofloxacin and Ornidazole Tablets I.P.) | B22122001Mfg 2022-01 · Exp 2023-12 | DissolutionDissolution | RDTL GuwahatiState lab | Sep 2022 |
| Tordex (Ambroxol Hydrochloride, Guaiphenesin, Terbutaline Sulphate and Menthol Syrup) | B16918001Mfg 2018-09 · Exp 2020-08 | pHpH | CDTL MumbaiCDSCO lab | Jan 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.